Chaoju Eye Care Holdings Limited reported that its issued share capital remained unchanged at 701.46 million ordinary shares as of 16 September 2026.

Between 31 August and 16 September 2026 the company repurchased 1.99 million shares that have yet to be cancelled, equivalent to approximately 0.29 % of the current outstanding share base.

Latest transaction • On 16 September 2026, Chaoju Eye Care bought back 82,500 shares on the Hong Kong Stock Exchange at prices ranging from HK$2.44 to HK$2.505, for a total consideration of HK$0.20 million. The volume-weighted average price for the day was HK$2.47 per share.

Cumulative statistics under the current mandate • Shareholders approved a repurchase mandate on 12 May 2026 covering up to 70.52 million shares. • To date, 5.34 million shares have been repurchased, utilizing roughly 7.57 % of the authorised limit.

Moratorium Under Hong Kong listing rules, the company is restricted from issuing new shares until 16 October 2026—30 days after the most recent buyback.

No new treasury shares were created or sold during the period. All repurchased shares are designated for cancellation, ensuring no change in total issued capital until the cancellation process is completed.